Exclusion criteria for VTE prophylaxis included coagulopathy, bleeding disorder, spinal epidural hematoma, hepatic failure, platelets less than or equal to 100×10 3 /μL, estimated creatinine ...
Our final sample included 32,104 patients who received prophylaxis at 333 hospitals ... small differences in comorbidities and individual VTE risk factors between the 2 groups.
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...
Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
VTE events with and without VTE prophylaxis during NACT. Characteristics No VTE Prophylaxis N=184 (63.4%) VTE Prophylaxis N=106 (36.5%) p-value ...
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B reactivation (HBVr) in at-risk individuals, recommending antiviral prophylaxis for ...
Clinical studies into compression are also lacking, and much of its rationale is extrapolated from research relating to deep venous thrombosis prophylaxis and lymphoedema management; there is little ...
If you haven’t already, make sure to renew to remain a part of this community and maintain access to your benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback